READY-TO-USE SYRINGE CONTAINING AMGEVITA 20 MG/0.4 ML SOLUTION FOR INJECTION, 1 PIECE - Turkey License a0ea7d8e3e143ddac3ecdf24bcfeaf2a
Access comprehensive regulatory information for READY-TO-USE SYRINGE CONTAINING AMGEVITA 20 MG/0.4 ML SOLUTION FOR INJECTION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number a0ea7d8e3e143ddac3ecdf24bcfeaf2a with license number 2021/31and contains active ingredient adalimumab. The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free Database
Powered by Pure Global AI
21,000+ Products
a0ea7d8e3e143ddac3ecdf24bcfeaf2a
License Details
Turkey SFDA License: a0ea7d8e3e143ddac3ecdf24bcfeaf2a
Product Details
READY-TO-USE SYRINGE CONTAINING AMGEVITA 20 MG/0.4 ML SOLUTION FOR INJECTION, 1 PIECE
TR: AMGEVİTA 20 MG/0.4 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADET
Pharmaceutical Product

